news

Our latest
Press Releases & Updates

Latest press releases

RetinAI and FVS Announce CE-MDR Certification for Co-developed AI-based Diabetic Retinopathy Screening Algorithm, LuxIA®

We are proud to announce the CE-MDR certification of LuxIA®! A new AI algorithm co-developed with Fundación Ver Salud for the analysis of Color Fundus images. The solution will be available on all our RetinAI Discovery products for the screening of diabetic adults for more-than-mild Diabetic Retinopathy (DR), facilitating earlier diagnosis and better care across Europe!

Ikerian Announces Series B Funding First close of USD 8M Led by Sanoptis with Commercial Agreement to Expand RetinAI Discovery in Europe

Ikerian has secured USD 8M (CHF 6.73M) in the first close of its Series B round, led by Sanoptis, to enhance its AI-driven RetinAI Discovery platform and expand into new therapeutic areas.

RetinAI Partners with MAXO to Advance Clinical Studies in Dry Eye Disease

RetinAI partners with MAXO and TFS HealthScience to support two pivotal dry eye disease studies.

Ikerian (parent company of RetinAI U.S. Inc.) receives EU-MDR Certificate for four devices, its Ophthalmology Data Platform and AI models

Swiss AI Day: Empower your business [JUNE'17]

RetinAI will be participating in the Swiss AI Day: EmPOWER your Business, taking place on June 14th in Bern, and featuring top speakers in finance, insurance, healthcare, life sciences and research in AI. Don't miss the date and register now!

Ready for MICCA! [MAY'17]

RetinAI + UniBern's collaboration on Optical Coherence Tomography (OCT) has outcome in a publication in the prestigious conference MICCAI'2017. Meet the RetinAI team in Quebec this September and have some discussions about Machine Learning in Ophthalmology.

‍

ARVO 2017, Baltimore [MAY'17]

Our team members travelled to the American Research in Vision and Ophthalmology (ARVO) conference 2017, in Baltimore, to present their products in the field of OCT image analysis and Fundus Imaging.

Our latest
Press Releases & Updates

Latest press releases

RetinAI and FVS Announce CE-MDR Certification for Co-developed AI-based Diabetic Retinopathy Screening Algorithm, LuxIA®

Ikerian Announces Series B Funding First close of USD 8M Led by Sanoptis with Commercial Agreement to Expand RetinAI Discovery in Europe

RetinAI Partners with MAXO to Advance Clinical Studies in Dry Eye Disease

Ikerian (parent company of RetinAI U.S. Inc.) receives EU-MDR Certificate for four devices, its Ophthalmology Data Platform and AI models

Latest updates

Swiss AI Day: Empower your business [JUNE'17]

Ready for MICCA! [MAY'17]

ARVO 2017, Baltimore [MAY'17]

Contact us for more informations! We are happy to hear from you!

Sign Up And Receive Our Latest Promotions!

Our latest Press Releases & Updates

Latest press releases

RetinAI and FVS Announce CE-MDR Certification for Co-developed AI-based Diabetic Retinopathy Screening Algorithm, LuxIA®

Ikerian Announces Series B Funding First close of USD 8M Led by Sanoptis with Commercial Agreement to Expand RetinAI Discovery in Europe

RetinAI Partners with MAXO to Advance Clinical Studies in Dry Eye Disease

Ikerian (parent company of RetinAI U.S. Inc.) receives EU-MDR Certificate for four devices, its Ophthalmology Data Platform and AI models

Latest updates

Swiss AI Day: Empower your business [JUNE'17]

Ready for MICCA! [MAY'17]

ARVO 2017, Baltimore [MAY'17]

Contact us for more informations! We are happy to hear from you!

Our latest
Press Releases & Updates